» Articles » PMID: 34220827

Regulatory T Cells Increase After Rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children

Overview
Journal Front Immunol
Date 2021 Jul 5
PMID 34220827
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myelin oligodendrocytes glycoprotein (MOG) antibody-associated disease (MOGAD) represent 25% of pediatric acquired demyelinating syndrome (ADS); 40% of them may relapse, mimicking multiple sclerosis (MS), a recurrent and neurodegenerative ADS, which is MOG-Abs negative.

Aims: To identify MOG antigenic immunological response differences between MOGAD, MS and control patients, and between relapsing non-relapsing subgroups of MOGAD.

Methods: Three groups of patients were selected: MOGAD (n=12 among which 5 relapsing (MOGR) and 7 non-relapsing (MOGNR)), MS (n=10) and control patients (n=7). Peripheral blood mononuclear cells (PBMC) collected at the time of the first demyelinating event were cultured for 48 h with recombinant human (rh)-MOG protein (10 μg/ml) for a specific stimulation or without stimulation as a negative control. The T cells immunophenotypes were analyzed by flow cytometry. CD4 T cells, T helper (Th) cells including Th1, Th2, and Th17 were analyzed by intracellular staining of cytokines. Regulatory T cells (T, Foxp3), CD45RAFoxp3 T and subpopulation naive T (CD45RAFoxp3), effector T (CD45RAFoxp3) and non-suppressive T (CD45RAFoxp3) proportions were determined.

Results: The mean onset age of each group, ranging from 9.9 to 13.8, and sex ratio, were similar between MOGR, MOGNR, MS and control patients as analyzed by one-way ANOVA and Chi-square test. When comparing unstimulated to rh-MOG stimulated T cells, a significant increase in the proportion of Th2 and Th17 cells was observed in MOGAD. Increase of Th17 cells was significant in MOGNR (means: 0.63 ± 0.15 1.36 ± 0.43; Wilcoxon-test = 0.03) but not in MOGR. CD4 T were significantly increased in MOGNR (means: 3.51 ± 0.7 4.59 ± 1.33; Wilcoxon-test = 0.046) while they decreased in MOGR. CD45RAFoxp3 T were significantly decreased in MOGR (means: 2.37 ± 0.23 1.99 ± 0.17; paired t-test = 0.021), but not in MOGNR. MOGR showed the highest ratio of effector T/non suppressive-T which was significantly higher than in MOGNR.

Conclusions: Our findings suggest that CD4 Th2 and Th17 cells are involved in the pathophysiology of MOGAD in children. The opposite response of T to rh-MOG in MOGNR, where CD4 T increased, and in MOGR, where CD45RAFoxp3 T decreased, suggests a probable loss of tolerance toward MOG autoantigen in MOGR which may explain relapses in this recurrent pediatric autoimmune disease.

Citing Articles

Elevated IL-17A-Secreting Regulatory T Cells in Sinonasal Tissues of Chronic Rhinosinusitis with Nasal Polyps.

Ryu G, Bae J, Yoo S, Kim E, Mo J Inflammation. 2025; .

PMID: 39753929 DOI: 10.1007/s10753-024-02227-8.


Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)-Monophasic Optic Neuritis and Epstein-Barr Virus (EBV): A Case Report of Rare Comorbid Diagnoses in an Adolescent From a Remote Greek Island.

Georgopoulou E, Palkopoulou M, Liakopoulos D, Kerazi E, Kalaentzis A, Barmparoussi V Cureus. 2024; 16(9):e68946.

PMID: 39381468 PMC: 11461040. DOI: 10.7759/cureus.68946.


The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease.

Liyanage G, Trewin B, Lopez J, Andersen J, Tea F, Merheb V J Neurol Neurosurg Psychiatry. 2024; 95(6):544-553.

PMID: 38290838 PMC: 11103329. DOI: 10.1136/jnnp-2023-332851.


Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases.

Li X, Wu W, Hou C, Zeng Y, Wu W, Chen L Front Immunol. 2023; 14:1162647.

PMID: 37342342 PMC: 10277863. DOI: 10.3389/fimmu.2023.1162647.


Attack phenotypes and disease course in pediatric MOGAD.

Santoro J, Beukelman T, Hemingway C, Hokkanen S, Tennigkeit F, Chitnis T Ann Clin Transl Neurol. 2023; 10(5):672-685.

PMID: 37000895 PMC: 10187731. DOI: 10.1002/acn3.51759.


References
1.
Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

2.
Probstel A, Dornmair K, Bittner R, Sperl P, Jenne D, Magalhaes S . Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology. 2011; 77(6):580-8. DOI: 10.1212/WNL.0b013e318228c0b1. View

3.
Marta C, Taylor C, Coetzee T, Kim T, Winkler S, Bansal R . Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci. 2003; 23(13):5461-71. PMC: 6741276. View

4.
Genain C, Abel K, Belmar N, Villinger F, Rosenberg D, Linington C . Late complications of immune deviation therapy in a nonhuman primate. Science. 1996; 274(5295):2054-7. DOI: 10.1126/science.274.5295.2054. View

5.
Krishnamoorthy G, Lassmann H, Wekerle H, Holz A . Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest. 2006; 116(9):2385-92. PMC: 1555668. DOI: 10.1172/JCI28330. View